mutations and complex kar yotype. It follows a linear evolution through the CLL clone from the recurrent acquisition of CDKN2A Not all sufferers with CLL call for therapy. Regardless of all recent innovations, the iwCLL even now recommends watchful observation for people with asymptomatic ailment